New indices of visceral adiposity and its correlation with hs-CRP in patients with obesity

Clinical and Experimental Medical Letters

Volumn 52, Issue 3-4, 2011, Pages 91-95

  Stepień, Anna ^a   Stepień, Mariusz ^a   Wlazeł, Rafał N ^a   Paradowski, Marek ^a   Rysz, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cardiovascular risk; Hs CRP; Obesity indices

Indexed keywords

C REACTIVE PROTEIN; EZETIMIBE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMEGA 3 FATTY ACID;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY ADIPOSITY INDEX; BODY MASS; C REACTIVE PROTEIN BLOOD LEVEL; CARDIOVASCULAR RISK; CLASSICAL OBESITY PARAMETER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; VISCERAL ADIPOSITY INDEX; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 84856011928     PISSN: 18952089     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chehrei A, Sadrnia S, Keshteli AH et al: Correlation of dyslipidemia with waist to height ratio, waist circumference, and body mass index in Iranian adults. Asia Pac J Clin Nutr, 2007; 16(2): 248-53
2. Dalton M, Cameron AJ, Zimmet PZ et al: Waist circumference, waisthip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Int Med, 2003; 254: 555-63
3. Amato MC, Giordano C, Galia M et al: Visceral Adiposity Index. A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care, 2010; 33(4): 920-22
4. Bergman RN, Stefanovski D, Buchanan TA et al: A Better Index of Body Adiposity. Obesity, 2011; 19(5): 1083-89
5. Lee CMY, Huxley RR, Widma RP et al: Indices of abdominal obesity are better discrimination of cardiovascular risk factor than BMI: a meta-analysis. J Clin Epidem, 2008; 61(7): 646-53
6. Knowles KM, Paiva LL, Sanchez SE et al: Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among Peruvian adults. Inter J Hypert, 2011; 10 pages, article ID 931402, doi: 10.4061/2011/931402
7. Gruson E, Montaye M, Kee F et al: Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study. Heart, 2010; 96(2): 136-40
8. Lapice E, Maione S, Patti L et al: Abdominal Adiposity Is Associated With Elevated C-Reactive Protein Independent of BMI in Healthy Nonobese People. Diabetes Care, 2009; 32(9): 1734-36
9. Clearfield MB: C-Reactive Protein: A New Risk Assessment Tool for Cardiovascular Disease. JAOA, 2005; 105(9): 409-16
10. Unek IT, Bayraktar F, Solmaz D et al: The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people. Clin Med Res, 2010; 8(2): 89-95
11. Angles-Cano E: How statins and fibrates lower CRP. Blood, 2004; 103(11): 3996-97
12. Brooks GC, Blaha MJ, Blumenthal RS: Relation of C-Reactive Protein to Abdominal Adiposity. Am J Cardiol, 2010; 106(1): 56-61
13. Park HS, Part JY, Yu R: Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes res Clin Pract, 2005; 69(1): 29-35
14. Bozorgmanesh M, Hadegh F, Azizi F: Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes. Lipids in Health and Disease 2011; 10: 88
15. Lin Ch-Ch, Kardia SLR, Li Ch-I et al: The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population. BMC Public Health, 2010; 10: 579. http:/www.biomedcentral.com/1471-2458/10/579